FLAMEON

This brand name is authorized in Nigeria.

Active ingredients

The drug FLAMEON contains one active pharmaceutical ingredient (API):

1	Buserelin UNII 13U86G7YSP - BUSERELIN ACETATE
	Buserelin is a synthetic peptide. It is a superactive analogue of natural gonadotrophin releasing hormone (gonadorelin, LHRH or GNRH). After an initial stimulation of gonadotrophin release, it down-regulates the hypothalanic-pituitary-gonadal axis.
	Read more about Buserelin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-100983	Solution for injection	Flameon 1 mg/mL Injection INJ_SOL 1 mg/mL 10 mL x 1's (in clear glass vials)	Solution for Injection	28/08/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L02AE01	Buserelin	L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02A Hormones and related agents → L02AE Gonadotropin releasing hormone analogues
Discover more medicines within L02AE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-100983